iShares NASDAQ US Biotechnology ETF
ETFETFISIN: IE00BYXG2H39
Ticker: BTEC
IE00BYXG2H39
BTEC
Price
Data
TER
0.15%Fund Volume
$554.26MAsset Class
OtherDistributing
NoReplication Method
Physical FullRegion
OtherCountry Based
IrelandIssuer
iSharesRegion Breakdown
🇺🇸
USA84.19%🇬🇧
United Kingdom5.77%🇳🇱
Netherlands2.29%🇫🇷
France1.58%🇮🇪
Ireland1.39%🇩🇪
Germany1.21%🇰🇾
Cayman Islands0.95%🏳️
Other0.86%🇩🇰
Denmark0.82%🇨🇦
Canada0.51%🇨🇭
Switzerland0.43%
Sector Breakdown
- Health Care99.91%
- Other0.09%
Frequently asked questions
What is the Total Expense Ratio (TER) of iShares NASDAQ US Biotechnology ETF?
The total expense ratio (TER) of iShares NASDAQ US Biotechnology ETF is 0.15%. The TER represents the annual fees charged by the ETF provider, covering management costs and operational expenses. A lower TER can enhance your investment returns over time.
What is the fund volume of iShares NASDAQ US Biotechnology ETF?
iShares NASDAQ US Biotechnology ETF has a fund volume of $554.26M. Fund volume indicates the total assets under management (AUM) and reflects the ETF's size and liquidity. Larger fund volumes generally offer better liquidity and tighter bid-ask spreads.
Is iShares NASDAQ US Biotechnology ETF paying dividends?
iShares NASDAQ US Biotechnology ETF is a Accumulating ETF. It reinvests dividends back into the fund, increasing the value of each share over time.
What is the replication method used by iShares NASDAQ US Biotechnology ETF?
iShares NASDAQ US Biotechnology ETF uses a physical full replication method. In this approach, the ETF purchases all the securities in the underlying index in the exact proportions as the index. This ensures the most precise tracking of the index's performance since the ETF's holdings mirror the index completely.
In which country is iShares NASDAQ US Biotechnology ETF domiciled?
iShares NASDAQ US Biotechnology ETF is domiciled in Ireland. The domicile country can affect tax implications and regulatory oversight, which may influence your investment decisions.
Pricing
1D span
$6.849$6.962
52W span
$5.416$7.178
Information
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index. The Index measures the performance of companies listed on the NASDAQ Stock Market that are classified as either biotechnology companies or pharmaceutical companies, according to their Industry Classification Benchmark (ICB) and that also meet other eligibility criteria as determined by NASDAQ, Inc. (the Index Provider), including minimum market capitalisation and liquidity requirements.
Identifier
ISIN
IE00BYXG2H39
Primary Ticker
BTEC